Medical Dermatology Leader Eliminates Data Silos and Gains Real-Time Monitoring
BARCELONA, Spain, Oct. 3, 2023/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LEO Pharma, a global leader in medical dermatology, is using Veeva Vault Safety to optimize its security operations. With this foundation, the company can seamlessly incorporate affiliates into safety workflows, drive operational efficiency, ensure compliance, and unify its global pharmacovigilance data on a single platform.
"LEO Pharma is deeply committed to the safety of patients who use its products," said Pilar Carrero, vice president of global safety at LEO Pharma. "With Veeva Vault Safety, we now have real-time visibility into adverse events and data transparency for members that helps us work even better together."
Vault Safety is helping LEO Pharma improve oversight of case intake, processing, submission and distribution, while streamlining safety workflows and eliminating data reconciliation with affiliates and partners. By standardizing drug development on Veeva Development Cloud, LEO Pharma can better connect safety with other crucial business areas, such as clinical, regulatory and quality.
“Now, all parties have visibility into case, ownership and status data, facilitating better collaboration and learning sharing,” explained John Lawrie, vice president of Vault Safety at Veeva. "Veeva is pleased to partner with LEO Pharma to make their security operations simpler and more effective."
Vault Safety is a safety case management system that enables end-to-end intake, processing and submission of adverse events for clinical and marketed products. It is part of the Veeva Development Cloud, the technology foundation for drug development that brings together clinical, regulatory, safety and quality applications to drive end-to-end business processes.
Additional informationTo learn more about Veeva Vault Safety, visit: veeva.com/eu/VaultSafetyConnect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest biopharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com/eu.
Veeva Forward-Looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we undertake no obligation to update such statements. There are numerous risks that could adversely affect our results, including the risks and uncertainties set forth in our Form 10-Q filing for the period ended July 31, 2023, which can be found here (a summary is on pages 38 and 39). of risks that may affect our business), and in our subsequent filings with the SEC, which can be accessed at sec.gov.
Contact:
Jeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com
Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/leo-pharma-conecta-a-sus-filiales-con-veeva-vault-safety-para-transformar-las-operaciones-de-seguridad-301946023.html
